Untersuchungen zur Assoziation von Polymorphismen in regulatorischen Elementen der Lipoproteinlipase und des Apolipoprotein E mit KHK und Triglyzerid-Stoffwechsel

Durch Atherosklerose bedingte Kardiovaskuläre Erkrankungen sind die Haupttodesursache in der westlichen Welt. Neben der familiären Disposition, dem Geschlecht und dem Lebensalter gibt es zahlreiche beeinflussbare Risikofaktoren für diese Erkrankungen. Zusätzlich zum Nikotin-Konsum, der arteriellen H...

Full description

Saved in:
Bibliographic Details
Main Author: Schell, Johanna Kristina
Contributors: Schäfer, Jürgen (Prof.) (Thesis advisor)
Format: Dissertation
Published: Philipps-Universität Marburg 2011
Innere Medizin
Online Access:PDF Full Text
Tags: Add Tag
No Tags, Be the first to tag this record!

1. Merkel, M., Eckel, R. H., Goldberg, I. J. (2002a) Lipoprotein lipase: genetics, lipid uptake, and regulation. J.Lipid Res. 43, 1997-2006

2. Hall, S., Talmud, P. J., Cook, D. G., Wicks, P. D., Rothwell, M. J., Strazzullo, P., Sagnella, G. A., Cappuccio, F. P. (2000) Frequency and allelic association of common variants in the lipoprotein lipase gene in different ethnic groups: the Wandsworth Heart and Stroke Study. Genet.Epidemiol. 18, 203-216

3. Hall, S., Chu, G., Miller, G., Cruickshank, K., Cooper, J. A., Humphries, S. E., Tal- mud, P. J. (1997) A common mutation in the lipoprotein lipase gene promoter, - 93T/G, is associated with lower plasma triglyceride levels and increased promo- ter activity in vitro. Arterioscler.Thromb.Vasc.Biol. 17, 1969-1976

4. Schaefer, J. R., Simon, B., Soufi, M., Sattler, A., Noll, B., Herzum, M., Maisch, B. (2000) Strategies to optimize CAD prevention in modern cardiology. The "Mar- burg CAD Prevention Project". Herz 25, 113-116

5. Hense, H. W., Schulte, H., Lowel, H., Assmann, G., Keil, U. (2003) Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohorts. Eur.Heart J. 24, 937-945

6. Shih, S. J., Allan, C., Grehan, S., Tse, E., Moran, C., Taylor, J. M. (2000) Duplicated downstream enhancers control expression of the human apolipoprotein E gene in macrophages and adipose tissue. J.Biol.Chem. 275, 31567-31572

7. Myers, R. M., Fischer, S. G., Lerman, L. S., Maniatis, T. (1985) Nearly all single ba- se substitutions in DNA fragments joined to a GC-clamp can be detected by de- naturing gradient gel electrophoresis. Nucleic Acids Res. 13, 3131-3145

8. Grundy, S. M., Balady, G. J., Criqui, M. H., Fletcher, G., Greenland, P., Hiratzka, L. F., Houston-Miller, N., Kris-Etherton, P., Krumholz, H. M., LaRosa, J., Ockene, I. S., Pearson, T. A., Reed, J., Washington, R., Smith, S. C., Jr. (1998) Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. Ameri- can Heart Association. Circulation 97, 1876-1887

9. Grundy, S. M., Bazzarre, T., Cleeman, J., D'Agostino, R. B., Sr., Hill, M., Houston- Miller, N., Kannel, W. B., Krauss, R., Krumholz, H. M., Lauer, R. M., Ockene, I. S., Pasternak, R. C., Pearson, T., Ridker, P. M., Wood, D. (2000) Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I. Circulation 101, E3-E11

10. Maeno, Y., Kashiwagi, A., Nishio, Y., Takahara, N., Kikkawa, R. (2000) IDL can sti- mulate atherogenic gene expression in cultured human vascular endothelial cells. Diabetes Res.Clin.Pract. 48, 127-138

11. Schoonjans, K., Gelman, L., Haby, C., Briggs, M., Auwerx, J. (2000) Induction of LPL gene expression by sterols is mediated by a sterol regulatory element and is independent of the presence of multiple E boxes. J.Mol.Biol. 304, 323-334

12. Kirchgessner, T. G., Chuat, J. C., Heinzmann, C., Etienne, J., Guilhot, S., Svenson, K., Ameis, D., Pilon, C., d'Auriol, L., Andalibi, A., . (1989a) Organization of the human lipoprotein lipase gene and evolution of the lipase gene family. Proc.Natl.Acad.Sci.U.S.A 86, 9647-9651

13. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol.Cell 2, 275-281

14. Mailly, F., Tugrul, Y., Reymer, P. W., Bruin, T., Seed, M., Groenemeyer, B. F., Asp- lund Carlson, A., Vallance, D., Winder, A. F., Miller, G. J., et al (1995) A common variant in the gene for lipoprotein lipase (Asp9-->Asn). Functional implications and prevalence in normal and hyperlipidemic subjects. Arteriosc- ler.Thromb.Vasc.Biol. 15, 468-478

15. Nagai, M., Yoshida, A., Sato, N. (1998) Additive effects of bovine serum albumin, dithiothreitol, and glycerol on PCR. Biochem.Mol.Biol.Int. 44, 157-163

16. Simonet, W. S., Bucay, N., Lauer, S. J., Taylor, J. M. (1993) A far-downstream he- patocyte-specific control region directs expression of the linked human apoli- poprotein E and C-I genes in transgenic mice. J.Biol.Chem. 268, 8221-8229

17. Mahley, R. W. (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622-630

18. Mahley, R. W. und Rall, S. C., Jr. (2000) Apolipoprotein E: far more than a lipid transport protein. Annu.Rev.Genomics Hum.Genet. 1:507-37., 507-537

19. Zechner, R., Moser, R., Newman, T. C., Fried, S. K., Breslow, J. L. (1991) Apoli- poprotein E gene expression in mouse 3T3-L1 adipocytes and human adipose tissue and its regulation by differentiation and lipid content. J.Biol.Chem. 266, 10583-10588

20. Zilversmit, D. B. (1973) A proposal linking atherogenesis to the interaction of endo- thelial lipoprotein lipase with triglyceride-rich lipoproteins. Circ.Res. 33, 633-638

21. Kugiyama, K., Doi, H., Motoyama, T., Soejima, H., Misumi, K., Kawano, H., Naka- gawa, O., Yoshimura, M., Ogawa, H., Matsumura, T., Sugiyama, S., Nakano, T., Nakajima, K., Yasue, H. (1998) Association of remnant lipoprotein levels with im- pairment of endothelium-dependent vasomotor function in human coronary arte- ries. Circulation 97, 2519-2526

22. Sheffield, V. C., Cox, D. R., Lerman, L. S., Myers, R. M. (1989) Attachment of a 40- base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. Proc.Natl.Acad.Sci.U.S.A 86, 232-236

23. Libby, P. (2000) Changing concepts of atherogenesis. J.Intern.Med. 247, 349-358

24. Kawasaki, S., Taniguchi, T., Fujioka, Y., Takahashi, A., Takahashi, T., Domoto, K., Taguchi, M., Ishikawa, Y., Yokoyama, M. (2000) Chylomicron remnant induces apoptosis in vascular endothelial cells. Ann.N.Y.Acad.Sci. 902, 336-341

25. Okumura, T., Fujioka, Y., Morimoto, S., Masai, M., Sakoda, T., Tsujino, T., Kashi- wamura, S., Okamura, H., Ohyanagi, M. (2006) Chylomicron remnants stimulate release of interleukin-1beta by THP-1 cells. J.Atheroscler.Thromb. 13, 38-45

26. Kamemura, K., Fujioka, Y., Takaishi, H., Takahashi, A., Taniguchi, T., Ishikawa, Y., Yokoyama, M. (2006) Chylomicron remnants upregulate CD40 expression via the ERK pathway and a redox-sensitive mechanism in THP-1 cells. Atherosclerosis 187, 257-264

27. Rios, D. L., Vargas, A. F., Ewald, G. M., Torres, M. R., Zago, A. J., Callegari- Jacques, S. M., Hutz, M. H. (2003) Common variants in the lipoprotein lipase ge- ne in Brazil: association with lipids and angiographically assessed coronary athe- rosclerosis. Clin.Chem.Lab Med. 41, 1351-1356

28. Myers, R. M., Maniatis, T., Lerman, L. S. (1987) Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol. 155, 501-527

29. Murdoch, S. J. und Breckenridge, W. C. (1996) Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL. Bio- chim.Biophys.Acta 1303, 222-232

30. Yusuf, S., Hawken, S., Ounpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., Lisheng, L. (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the IN- TERHEART study): case-control study. Lancet 364, 937-952

31. Klouche, M., Rose-John, S., Schmiedt, W., Bhakdi, S. (2000) Enzymatically degra- ded, nonoxidized LDL induces human vascular smooth muscle cell activation, fo- am cell transformation, and proliferation. Circulation 101, 1799-1805

32. Hokanson, J. E. (1999) Functional variants in the lipoprotein lipase gene and risk cardiovascular disease. Curr.Opin.Lipidol. 10, 393-399

33. Weisgraber, K. H., Rall, S. C., Jr., Mahley, R. W. (1981) Human E apoprotein hete- rogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo- E isoforms. J.Biol.Chem. 256, 9077-9083

34. Sparkes, R. S., Zollman, S., Klisak, I., Kirchgessner, T. G., Komaromy, M. C., Mo- handas, T., Schotz, M. C., Lusis, A. J. (1987) Human genes involved in lipolysis of plasma lipoproteins: mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21. Genomics 1, 138-144

35. Wion, K. L., Kirchgessner, T. G., Lusis, A. J., Schotz, M. C., Lawn, R. M. (1987) Human lipoprotein lipase complementary DNA sequence. Science 235, 1638- 1641

36. Merkel, M., Heeren, J., Dudeck, W., Rinninger, F., Radner, H., Breslow, J. L., Gold- berg, I. J., Zechner, R., Greten, H. (2002b) Inactive lipoprotein lipase (LPL) alone increases selective cholesterol ester uptake in vivo, whereas in the presence of active LPL it also increases triglyceride hydrolysis and whole particle lipoprotein uptake. J.Biol.Chem. 277, 7405-7411

37. Libby, P. (2002) Inflammation in atherosclerosis. Nature 420, 868-874

38. Libby, P., Ridker, P. M., Hansson, G. K. (2009) Inflammation in atherosclerosis: from pathophysiology to practice. J.Am.Coll.Cardiol. 54, 2129-2138

39. Murdoch, S. J. und Breckenridge, W. C. (1995) Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL. Atherosclerosis 118, 193-212

40. Nakshatri, H., Nakshatri, P., Currie, R. A. (1995) Interaction of Oct-1 with TFIIB. Implications for a novel response elicited through the proximal octamer site of the lipoprotein lipase promoter. J.Biol.Chem. 270, 19613-19623

41. Kastelein, J. J., Jukema, J. W., Zwinderman, A. H., Clee, S., van Boven, A. J., Jan- sen, H., Rabelink, T. J., Peters, R. J., Lie, K. I., Liu, G., Bruschke, A. V., Hayden, M. R. (2000) Lipoprotein lipase activity is associated with severity of angina pec- toris. REGRESS Study Group. Circulation 102, 1629-1633

42. M., Strickland, D. K., Chappell, D. A. (1996) Lipoprotein lipase binds to low densi- ty lipoprotein receptors and induces receptor-mediated catabolism of very low density lipoproteins in vitro. J.Biol.Chem. 271, 17073-17080

43. Preiss-Landl, K., Zimmermann, R., Hammerle, G., Zechner, R. (2002) Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism. Curr.Opin.Lipidol. 13, 471-481

44. Hessler, J. R., Morel, D. W., Lewis, L. J., Chisolm, G. M. (1983) Lipoprotein oxidati- on and lipoprotein-induced cytotoxicity. Arteriosclerosis 3, 215-222

45. Tacken, P. J., Hofker, M. H., Havekes, L. M., Van Dijk, K. W. (2001) Living up to a name: the role of the VLDL receptor in lipid metabolism. Curr.Opin.Lipidol. 12, 275-279

46. Scott, J., Knott, T. J., Shaw, D. J., Brook, J. D. (1985) Localization of genes enco- ding apolipoproteins CI, CII, and E to the p13----cen region of human chromoso- me 19. Hum.Genet. 71, 144-146

47. M. (1993) Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipopro- tein lipase. J.Biol.Chem. 268, 9369-9375

48. Talmud, P. J., Hall, S., Holleran, S., Ramakrishnan, R., Ginsberg, H. N., Humphries, S. E. (1998) LPL promoter -93T/G transition influences fasting and postprandial plasma triglycerides response in African-Americans and Hispanics. J.Lipid Res. 39, 1189-1196

49. Libby, P. (2009) Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis. J.Lipid Res. 50 Suppl, S352-S357

50. Simonet, W. S., Bucay, N., Pitas, R. E., Lauer, S. J., Taylor, J. M. (1991) Multiple tissue-specific elements control the apolipoprotein E/C-I gene locus in transgenic mice. J.Biol.Chem. 266, 8651-8654

51. Haley, K. J., Lilly, C. M., Yang, J. H., Feng, Y., Kennedy, S. P., Turi, T. G., Thomp- son, J. F., Sukhova, G. H., Libby, P., Lee, R. T. (2000) Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation 102, 2185-2189

52. Mahley, R. W., Huang, Y., Rall, S. C., Jr. (1999) Pathogenesis of type III hyperli- poproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes.

53. Sun, Y., Hegamyer, G., Colburn, N. H. (1993) PCR-direct sequencing of a GC-rich region by inclusion of 10% DMSO: application to mouse c-jun. Biotechniques 15, 372-374

54. Utermann, G., Hees, M., Steinmetz, A. (1977) Polymorphism of apolipoprotein E and occurence of dysbetalipoproteinaemia in man. Nature 269, 604-607

55. Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., Erlich, H. A. (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239, 487-491

56. Goudriaan, J. R., Tacken, P. J., Dahlmans, V. E., Gijbels, M. J., Van Dijk, K. W., Havekes, L. M., Jong, M. C. (2001) Protection from obesity in mice lacking the VLDL receptor. Arterioscler.Thromb.Vasc.Biol. 21, 1488-1493

57. Schaefer, J. R. (1998) Präventive Kardiologie. Prophylaxe der koronaren Herz- krankheit. (Schattauer Verlag, Stuttgart --New York)

58. Yang, W. S., Nevin, D. N., Iwasaki, L., Peng, R., Brown, B. G., Brunzell, J. D., Deeb, S. S. (1996) Regulatory mutations in the human lipoprotein lipase gene in pati- ents with familial combined hyperlipidemia and coronary artery disease. J.Lipid Res. 37, 2627-2637

59. Kawakami, A., Tanaka, A., Chiba, T., Nakajima, K., Shimokado, K., Yoshida, M. (2003) Remnant lipoprotein-induced smooth muscle cell proliferation involves e- pidermal growth factor receptor transactivation. Circulation 108, 2679-2688

60. Menotti, A., Scanga, M., Morisi, G. (1994) Serum triglycerides in the prediction of coronary artery disease (an Italian experience). Am.J.Cardiol. 73, 29-32

61. Sagoo, G. S., Tatt, I., Salanti, G., Butterworth, A. S., Sarwar, N., van Maarle, M., Jukema, J. W., Wiman, B., Kastelein, J. J., Bennet, A. M., De Faire, U., Danesh, J., Higgins, J. P. (2008) Seven lipoprotein lipase gene polymorphisms, lipid frac- tions, and coronary disease: a HuGE association review and meta-analysis.

62. Yang, W. S. und Deeb, S. S. (1998) Sp1 and Sp3 transactivate the human lipopro- tein lipase gene promoter through binding to a CT element: synergy with the ste- rol regulatory element binding protein and reduced transactivation of a naturally occurring promoter variant. J.Lipid Res. 39, 2054-2064

63. Mullis, K., Faloona, F., Scharf, S., Saiki, R., Horn, G., Erlich, H. (1986) Specific en- zymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb.Symp.Quant.Biol. 51 Pt 1, 263-273

64. Mullis, K. B. und Faloona, F. A. (1987) Specific synthesis of DNA in vitro via a poly- merase-catalyzed chain reaction. Methods Enzymol. 155, 335-350

65. Krieger, M. und Herz, J. (1994) Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu.Rev.Biochem. 63, 601-637

66. Osborne, J. C., Jr., Bengtsson-Olivecrona, G., Lee, N. S., Olivecrona, T. (1985) Studies on inactivation of lipoprotein lipase: role of the dimer to monomer disso- ciation. Biochemistry 24, 5606-5611

67. W., Gagne, S. E., Jansen, H., Seidell, J. C., Kromhout, D., Jukema, J. W., Bruschke, A. V., Boerwinkle, E., Hayden, M. R. (1998) The Asn9 variant of li- poprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study Group. Clin.Genet. 53, 27-33

68. Williams, S. E., Inoue, I., Tran, H., Fry, G. L., Pladet, M. W., Iverius, P. H., Lalouel, J. M., Chappell, D. A., Strickland, D. K. (1994) The carboxyl-terminal domain of lipoprotein lipase binds to the low density lipoprotein receptor-related prote- in/alpha 2-macroglobulin receptor (LRP) and mediates binding of normal very low density lipoproteins to LRP. J.Biol.Chem. 269, 8653-8658

69. Ross, R. (1986) The pathogenesis of atherosclerosis--an update. N.Engl.J.Med. 314, 488-500

70. Takahashi, S., Sakai, J., Fujino, T., Hattori, H., Zenimaru, Y., Suzuki, J., Miyamori, I., Yamamoto, T. T. (2004) The very low-density lipoprotein (VLDL) receptor: cha- racterization and functions as a peripheral lipoprotein receptor.

71. World Health Organization (2004) The World Health report 2004 annex Table 2. Deaths by cause, sex and mortality stratum in WHO regions, estimates for 2003. Geneva: World Health Organization Yamamoto, T., Takahashi, S., Sakai, J., Kawarabayasi, Y. (1993) The very low den- sity lipoprotein receptor: A second lipoprotein receptor that may mediate uptake of fatty acids into muscle and fat cells. Trends Cardiovasc.Med. 3, 144-148

72. Zannis, V. I., Kan, H. Y., Kritis, A., Zanni, E., Kardassis, D. (2001) Transcriptional regulation of the human apolipoprotein genes. Front Biosci. 6, D456-D504

73. Jeppesen, J., Hein, H. O., Suadicani, P., Gyntelberg, F. (1998) Triglyceride con- centration and ischemic heart disease: an eight-year follow-up in the Copenha- gen Male Study. Circulation 97, 1029-1036

74. Rapp, J. H., Lespine, A., Hamilton, R. L., Colyvas, N., Chaumeton, A. H., Tweedie Hardman, J., Kotite, L., Kunitake, S. T., Havel, R. J., Kane, J. P. (1994) Triglyce- ride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immuno- sorption from human atherosclerotic plaque. Arterioscler.Thromb. 14, 1767-1774

75. Hufnagel, B., Dworak, M., Soufi, M., Mester, Z., Zhu, Y., Schaefer, J. R., Klumpp, S., Krieglstein, J. (2005) Unsaturated fatty acids isolated from human lipoproteins ac- tivate protein phosphatase type 2Cbeta and induce apoptosis in endothelial cells. Atherosclerosis 180, 245-254

76. Niemeier, A., Gafvels, M., Heeren, J., Meyer, N., Angelin, B., Beisiegel, U. (1996) VLDL receptor mediates the uptake of human chylomicron remnants in vitro. J.Lipid Res. 37, 1733-1742

77. Kostner, G. M., Scharnagl, H., Kostner K., Maerz, W. (2006). Zusammensetzung und Stoffwechsel der Lipoproteine In Handbuch der Fettstoffwechselstörungen von Schwandt, P., (Schattauer Verlag, pp. 2:65

78. Radha, V., Vimaleswaran, K. S., Ayyappa, K. A., Mohan, V. (2007) Association of lipoprotein lipase gene polymorphisms with obesity and type 2 diabetes in an A- sian Indian population. Int.J.Obes.(Lond) 31, 913-918

79. Kirchgessner, T. G., LeBoeuf, R. C., Langner, C. A., Zollman, S., Chang, C. H., Tay- lor, B. A., Schotz, M. C., Gordon, J. I., Lusis, A. J. (1989b) Genetic and develop- mental regulation of the lipoprotein lipase gene: loci both distal and proximal to the lipoprotein lipase structural gene control enzyme expression. J.Biol.Chem. 264, 1473-1482

80. Yang, W. S., Nevin, D. N., Peng, R., Brunzell, J. D., Deeb, S. S. (1995) A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial com- bined hyperlipidemia and low LPL activity. Proc.Natl.Acad.Sci.U.S.A. 92, 4462- 4466

81. Laffitte, B. A., Repa, J. J., Joseph, S. B., Wilpitz, D. C., Kast, H. R., Mangelsdorf, D. J., Tontonoz, P. (2001) LXRs control lipid-inducible expression of the apolipopro- tein E gene in macrophages and adipocytes. Proc.Natl.Acad.Sci.U.S.A 98, 507- 512

82. Henke, W., Herdel, K., Jung, K., Schnorr, D., Loening, S. A. (1997) Betaine impro- ves the PCR amplification of GC-rich DNA sequences. Nucleic Acids Res. 25, 3957-3958

83. Apolipoprotein A5 and lipoprotein lipase interact to modulate anthropo- metric measures in Hispanics of Caribbean origin. Obesity.(Silver.Spring) 18, 327-332

84. Kannel, W. B. und Vasan, R. S. (2009) Triglycerides as vascular risk factors: new epidemiologic insights. Curr.Opin.Cardiol. 24, 345-350

85. Steinbrecher, U. P., Parthasarathy, S., Leake, D. S., Witztum, J. L., Steinberg, D. (1984) Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.

86. Mach, F., Sauty, A., Iarossi, A. S., Sukhova, G. K., Neote, K., Libby, P., Luster, A. D. (1999) Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J.Clin.Invest 104, 1041-1050

87. Saxena, U., Klein, M. G., Vanni, T. M., Goldberg, I. J. (1992) Lipoprotein lipase inc- reases low density lipoprotein retention by subendothelial cell matrix. J.Clin.Invest 89, 373-380

88. Schoonjans, K., Peinado-Onsurbe, J., Lefebvre, A. M., Heyman, R. A., Briggs, M., Deeb, S., Staels, B., Auwerx, J. (1996) PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipopro- tein lipase gene. EMBO J. 15, 5336-5348

89. Takahashi, S., Kawarabayasi, Y., Nakai, T., Sakai, J., Yamamoto, T. (1992) Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like prote- in with distinct ligand specificity. Proc.Natl.Acad.Sci.U.S.A. 89, 9252-9256

90. Yla-Herttuala, S., Lipton, B. A., Rosenfeld, M. E., Goldberg, I. J., Steinberg, D., Witz- tum, J. L. (1991) Macrophages and smooth muscle cells express lipoprotein lipa- se in human and rabbit atherosclerotic lesions. Proc.Natl.Acad.Sci.U.S.A 88, 10143-10147

91. World Health Organization (1958) Classification of atherosclerotic lesions; report of a study group. World Health Organ Tech.Rep.Ser. 57, 1-20

92. Wittrup, H. H., Andersen, R. V., Tybjaerg-Hansen, A., Jensen, G. B., Nordestgaard, B. G. (2006) Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross- sectional, prospective, and case-control studies from the Copenhagen City Heart Study. J.Clin.Endocrinol.Metab 91, 1438-1445